Murray D K, Hill M E, Nelson D H
Department of Medicine, University of Utah School of Medicine, Salt Lake City 84132.
Life Sci. 1990;46(25):1843-9. doi: 10.1016/0024-3205(90)90236-k.
The mechanism of the inhibitory action of glucocorticoids on glucose uptake is incompletely understood. Treatment with corticosteroids of cells in which glucose uptake is stimulated at insulin postbinding and postreceptor sites may clarify the site of the steroid inhibitory action. Hydrogen peroxide, which has been shown to stimulate the insulin receptor tyrosine kinase, and phorbol myristate acetate (PMA) which stimulates protein kinase C were, therefore, used as stimulators of glucose transport in this study. These studies demonstrate that dexamethasone and the sphingoid bases, sphinganine and sphingosine, inhibit glucose uptake that has been stimulated at either the receptor kinase or protein kinase C level in both 3T3-L1 and 3T3-C2 cells. These data confirm glucocorticoid inhibitory action at a post binding level and support the suggestion that some corticosteroid inhibitory effects may be mediated by an action on sphingolipid metabolism.
糖皮质激素对葡萄糖摄取的抑制作用机制尚未完全明确。用皮质类固醇处理在胰岛素结合后和受体后位点刺激葡萄糖摄取的细胞,可能会阐明类固醇抑制作用的位点。因此,在本研究中,已被证明可刺激胰岛素受体酪氨酸激酶的过氧化氢和可刺激蛋白激酶C的佛波酯肉豆蔻酸酯(PMA)被用作葡萄糖转运的刺激剂。这些研究表明,地塞米松以及鞘氨醇碱、二氢鞘氨醇和鞘氨醇,在3T3-L1和3T3-C2细胞中,均可抑制在受体激酶或蛋白激酶C水平上被刺激的葡萄糖摄取。这些数据证实了糖皮质激素在结合后水平的抑制作用,并支持了某些皮质类固醇抑制作用可能是通过对鞘脂代谢的作用来介导的这一观点。